prenatalinformation.org
Legal blow to Sequenom as global NIPT market expands
Claims that a key US patent no. 6,258,540 held by Sequenom, the molecular diagnostic testing company that began the now the increasingly contested non-invasive prenatal testing (NIPT) commercial ma…